Quanterix Corporation (NASDAQ:QTRX) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET

Company Participants

Vandana Sriram - CFO

Masoud Toloue - President and CEO

Conference Call Participants

Jake Allen - Goldman Sachs

Sung Ji Nam - Scotiabank

Kyle Mikson - Canaccord Genuity

Puneet Souda - Leerink Partners

Thomas DeBourcy - Nephron Research

Operator

Thank you for standing by. My name is Andrea and I will be your conference operator today. At this time, I would like to welcome everyone to the Quanterix Corporation Q3 2024 Earnings Call. All lines have been placed in mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. [Operator Instructions]

I would now like to turn the call over to Vandana Sriram. Thank you. Please go ahead.

Vandana Sriram

Thank you and good afternoon. With me on today's call is Masoud Toloue, Quanterix's President and CEO. Before we begin, I would like to remind you of a few things. This call will be recorded and a replay will be available for investors on the investors section of our website.

Today's call will contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act. These forward-looking statements include, among other things, statements regarding our preliminary results for the third quarter and the expected impact of the restatement of our historical financial statements.

These forward-looking statements are based on management's beliefs and assumptions and based on information available as of the date of this call. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.

The risks and uncertainties that we face include that we may have underestimated the scope and impact of the restatement, risks and uncertainties around the effectiveness of our internal control over financial reporting, the risk that our restated financial statements may take longer to complete than expected, and other risks described in our filings with the Securities and Exchange Commission.

To supplement our preliminary financial statements presented on a GAAP basis, we have provided certain preliminary non-GAAP financial measures. These preliminary non-GAAP measures are used to evaluate our operating performance in a manner that allows for meaningful period-to-period comparison and analysis of trends in our business and our competitors. We believe that such measures are important in comparing current results with other periods' results and assessing our operating performance within our industry.